White papers and other resources

September 3, 2024
White Paper
Genialis™ krasID White Paper
February 10, 2024
White Paper
RNA: the Future of Predictive Biomarkers
December 13, 2023
Tutorial
Normalizing RNA-seq data in Python with RNAnorm

Scientific journals

February 19, 2024
European Journal of Pharmaceutical Sciences
Transcriptome analysis reveals involvement of thiopurine S-methyltransferase in oxidation-reduction processes
May 23, 2023
Frontiers in Oncology
Xerna™ TME Panel is a machine learning-based transcriptomic biomarker designed to predict therapeutic response in multiple cancers
December 1, 2022
Journal of Personalized Medicine
Pitfalls and Rewards of Setting Up a Liquid Biopsy Approach for the Detection of Driver Mutations in Circulating Tumor DNAs: Our Institutional Experience
May 17, 2022
Journal of Clinical Oncology
Phase Ib Study of Navicixizumab Plus Paclitaxel in Patients With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Conference posters

May 30, 2025
ASCO 2025
Prediction of sotorasib response duration and identification of clinically actionable resistance mechanisms using an RNA-based patient classifier
April 17, 2025
AACR 2025
Genialis™ Supermodel: Predicting monotherapy and combination therapy responses in KRAS-mutated cancers using a large molecular model of cancer biology
April 17, 2025
AACR 2025
Biology-driven, machine learning-based development of a biomarker to predict response to WEE1 inhibitor Debio 0123
October 24, 2024
EORTC ENA 2024
Molecular biomarker testing in Slovenian non-small cell lung cancer patients in early and late stages of the disease
September 25, 2024
RAS-Targeted Drug Development Summit 2024
Genialis™ krasID: Biology-driven Machine Learning to Personalize KRAS Inhibitor Therapy
April 9, 2024
AACR 2024
Genialis™ krasID: Biology-Driven Machine Learning to Personalize KRAS Inhibitor Therapy
December 7, 2023
SABC 2023
Prevalence of genomic alterations in Xerna tumor microenvironment subtypes in triple negative breast cancer patients
November 3, 2023
SITC 2023
Prevalence of genomic alterations in Xerna tumor microenvironment subtypes in colorectal cancer patients

Genialis Highlights Power of its Supermodel to Predict and Explain Therapeutic Response at AACR 2025. Read the press release →

Genialis Highlights Power of its Supermodel to Predict and Explain Therapeutic Response at AACR 2025. Read the press release → Genialis Highlights Power of its Supermodel to Predict and Explain Therapeutic Response at AACR 2025. Read the press release →

This website uses cookies and third party services. Read More Accept Reject